Filing Flows › BioAge Labs (BIOA) › Who owns the stock
Who owns BioAge Labs (BIOA) stock
143 funds reported BioAge Labs (BIOA) shares in their latest 13F filings, worth $927M in all. The largest holder is AH Capital Management, L.L.C. ($79.2M). Last quarter 82 funds added to their stakes and 52 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| AH Capital Management, L.L.C. | 3,233,170 | $79.2M | unchanged | 2026-06-30 |
| BlackRock | 2,849,077 | $69.8M | increase | 2026-06-30 |
| Cormorant Asset Management, LP | 2,390,605 | $58.6M | decrease | 2026-06-30 |
| Sofinnova Investments | 2,293,788 | $56.2M | unchanged | 2026-06-30 |
| Jupiter Topco LLC | 2,144,633 | $52.6M | base | 2026-06-30 |
| Octagon Capital Advisors LP | 1,748,000 | $42.8M | unchanged | 2026-06-30 |
| RA Capital Management, L.P. | 1,671,648 | $41.0M | increase | 2026-06-30 |
| MPM BioImpact LLC | 1,667,661 | $40.9M | new | 2026-06-30 |
| Vanguard Capital Management LLC | 1,544,214 | $37.8M | increase | 2026-06-30 |
| Janus Henderson Group | 2,094,270 | $36.6M | increase | 2026-03-31 |
| Polar Capital Holdings | 1,072,344 | $26.3M | decrease | 2026-06-30 |
| State Street | 1,021,464 | $25.0M | increase | 2026-06-30 |
| Geode Capital Management, LLC | 1,004,264 | $24.6M | increase | 2026-06-30 |
| Vanguard Group | 1,414,770 | $18.7M | decrease | 2025-12-31 |
| Orbimed Advisors LLC | 752,153 | $18.4M | increase | 2026-06-30 |
BioAge Labs' latest quarter
BioAge Labs, Q3 2026: revenue $298K (-86% year over year), net loss $33.5M, operating cash flow −$31.0M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most BIOA stock?
By the latest 13F filings: AH Capital Management, L.L.C. ($79.2M); BlackRock ($69.8M); Cormorant Asset Management, LP ($58.6M); Sofinnova Investments ($56.2M); Jupiter Topco LLC ($52.6M).
What is the short interest in BIOA?
3,431,572 shares were sold short at the 2026-10-15 settlement, 4.8% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.